Search Count: 12
 |
Structure Of Human Enolase 2 With ((3S,5S)-1,5-Dihydroxy-3-Methyl-2-Oxopyrrolidin-3-Yl)Phosphonate (Purified Enantiomer)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.63 Å Release Date: 2017-10-18 Classification: LYASE/LYASE INHIBITOR Ligands: 5TX, MG |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2017-10-18
Ligands: 5TX, MG
 |
Structure Of Human Enolase 2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.32 Å Release Date: 2017-09-27 Classification: LYASE Ligands: MG, CL |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2017-09-27
Ligands: MG, CL
 |
X-Ray Crystal Structure Of Archaeoglobus Fulgidus Rio1 Bound To (2E)-N-Benzyl-2-Cyano-3-(Pyridine-4-Yl)Acrylamide (Wp1086)
Organism: Archaeoglobus fulgidus
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2013-04-24 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 1L7 |
Organism: Archaeoglobus fulgidus
Method: X-RAY DIFFRACTION
Release Date: 2013-04-24
Ligands: 1L7
 |
Binding Of The Modified Daunorubicin Wp401 Adjacent To A T-G Base Pair Induces The Reverse Watson-Crick Conformation: Crystal Structures Of The Wp401-Tggccg And Wp401-Cgg[Br5C]Cg Complexes
Method: X-RAY DIFFRACTION
Resolution:2.00 Å Release Date: 1998-07-13 Classification: DNA Ligands: DM8 |
Method: X-RAY DIFFRACTION
Release Date: 1998-07-13
Ligands: DM8
 |
Binding Of The Modified Daunorubicin Wp401 Adjacent To A T-G Base Pair Induces The Reverse Watson-Crick Conformation: Crystal Structures Of The Wp401-Tggccg And Wp401-Cgg[Br5C]Cg Complexes
Method: X-RAY DIFFRACTION
Resolution:2.10 Å Release Date: 1998-07-13 Classification: DNA Ligands: DM8 |
Method: X-RAY DIFFRACTION
Release Date: 1998-07-13
Ligands: DM8
 |
Nmr Study Of Dna (5'-D(*Ap*Cp*Gp*Tp*Ap*Cp*Gp*T)-3') Self-Complementary Duplex Complexed With A Bis-Daunorubicin, Minimized Average Structure
|
Method: SOLUTION NMR
Release Date: 1997-09-17
Ligands: BDA
 |
Nmr Study Of Dna (5'-D(*Tp*Gp*Tp*Ap*Cp*A)-3') Self-Complementary Duplex Complexed With A Bis-Daunorubicin Wp-652, Minimized Average Structure
|
Method: SOLUTION NMR
Release Date: 1997-09-17
Ligands: BNR
 |
Structure Of A Dna-Bisdaunomycin Complex
Method: X-RAY DIFFRACTION
Resolution:2.20 Å Release Date: 1997-04-29 Classification: DNA Ligands: BDA |
Method: X-RAY DIFFRACTION
Release Date: 1997-04-29
Ligands: BDA
 |
Substitutions At C2' Of Daunosamine In The Anticancer Daunorubicin Alter Its Dna-Binding Sequence Specificity
Method: X-RAY DIFFRACTION
Resolution:1.80 Å Release Date: 1996-09-16 Classification: DNA Ligands: DM8 |
Method: X-RAY DIFFRACTION
Release Date: 1996-09-16
Ligands: DM8
 |
Substitutions At C2' Of Daunosamine In The Anticancer Daunorubicin Alter Its Dna-Binding Sequence Specificity
Method: X-RAY DIFFRACTION
Resolution:1.80 Å Release Date: 1996-09-16 Classification: DNA Ligands: DM8 |
Method: X-RAY DIFFRACTION
Release Date: 1996-09-16
Ligands: DM8
 |
Substitutions At C2' Of Daunosamine In The Anticancer Daunorubicin Alter Its Dna-Binding Sequence Specificity
Method: X-RAY DIFFRACTION
Resolution:1.80 Å Release Date: 1996-09-16 Classification: DNA Ligands: DM8 |
Method: X-RAY DIFFRACTION
Release Date: 1996-09-16
Ligands: DM8
 |
Substitutions At C2' Of Daunosamine In The Anticancer Daunorubicin Alter Its Dna-Binding Sequence Specificity
Method: X-RAY DIFFRACTION
Resolution:1.80 Å Release Date: 1996-09-16 Classification: DNA Ligands: DM8 |
Method: X-RAY DIFFRACTION
Release Date: 1996-09-16
Ligands: DM8